BL

Bradley Latham

Algorae Pharmaceuticals Limited | Non-Executive Director
Mr Latham is businessperson with commercial acumen and business experience. The majority of Mr Latham's working career has been with Sydney Markets where he has worked his way through the ranks until appointed CEO of the group in 2006. Mr Latham has a track record of business leadership and has understanding of good corporate governance and risk management. He possesses an ability to identify and assess strategic growth opportunities.

Company and Role

Company
Title
Tenure
Since
1AI
Algorae Pharmaceuticals Limited
  • Non-Executive Director
2yrsJul 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
1AI
Algorae Pharmaceuticals Limited
30/06/2420,000,000N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
1AI
Algorae Pharmaceuticals Limited
28/12/23
Exercise
5,000,000$0.011$55,000Conversion of securities
1AI
Algorae Pharmaceuticals Limited
28/12/23
Buy
5,000,000$0.011$55,000Conversion of securities
1AI
Algorae Pharmaceuticals Limited
09/11/23
Issued
20,000,000$0.013$260,000Issue of securities
1AI
Algorae Pharmaceuticals Limited
02/11/23
Exercise
5,000,000$0.014$70,000Conversion of securities
1AI
Algorae Pharmaceuticals Limited
02/11/23
Buy
5,000,000$0.014$70,000Conversion of securities